Amicus Therapeutics Inc (FOLD):企業のM&A・提携動向(医療分野)

GlobalDataが発行した調査報告書(GDPH58553D)
◆英語タイトル:Amicus Therapeutics Inc (FOLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH58553D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年2月17日
◆ページ数:35
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company. It focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. It develops novel, drugs with focus on improved therapies for treating lysosomal storage diseases and diseases of neurodegeneration. The company’s lead product migalastat Hcl, used for the treatment of Fabry disease. The other development products in the pipeline include ATB200 for the treatment of pompe disease; AT2101 for the treatment of Gaucher disease; AT3375 for Parkinson’s disease in Gaucher disease carriers and others. It has presence in the US and the UK. Amicus Therapeutics is headquartered in New Jersey, the US.

Amicus Therapeutics Inc (FOLD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Amicus Therapeutics Raises USD4.7 Million in Venture Financing 11
Scioderm Raises USD20 Million in Series B Venture Financing 11
Callidus Biopharma Raises US$4.6 Million In Series A Financing 12
Scioderm Raises US$16 Million In Series A Financing 13
Partnerships 14
Amicus Therapeutics Enters Into Co-Development Agreement With Biogen Idec 14
Licensing Agreements 15
Amicus Therapeutics Amends Licensing Agreement With GlaxoSmithKline For Amigal 15
Scioderm Plans To License Pharmaceuticals To Develop Topical Products 17
GlaxoSmithKline Extends Licensing Agreement With Amicus Therapeutics For Amigal 17
Equity Offering 19
Amicus Therapeutics Raises USD258.8 Million in Public Offering of Shares 19
Amicus Therapeutics Raises USD103.5 Million in Public Offering of Shares 20
Amicus Therapeutics Announces Public Offering Of Shares For Up To US$40 Million 22
Amicus Therapeutics Completes Private Placement Of Securities For US$15 Million 22
Amicus Therapeutics Files Registration Statement For Public Offering Of Securities For US$145 Million 24
Amicus Therapeutics Completes Public Offering Of Common Stock For US$65 Million 24
Debt Offering 26
Amicus Therapeutics Raises USD250 Million in Private Placement of 3% Notes Due 2023 26
Amicus Therapeutics Announces Public Offering Of Debt Securities For US$25 Million 27
Acquisition 28
Amicus Therapeutics Acquires MiaMed 28
Amicus Therapeutics Acquires Scioderm 29
Amicus Therapeutics Acquires Callidus Biopharma, Drug Discovery Company, For US$130 Million 30
Amicus Therapeutics Inc – Key Competitors 32
Key Employees 33
Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amicus Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Amicus Therapeutics Raises USD4.7 Million in Venture Financing 11
Scioderm Raises USD20 Million in Series B Venture Financing 11
Callidus Biopharma Raises US$4.6 Million In Series A Financing 12
Scioderm Raises US$16 Million In Series A Financing 13
Amicus Therapeutics Enters Into Co-Development Agreement With Biogen Idec 14
Amicus Therapeutics Amends Licensing Agreement With GlaxoSmithKline For Amigal 15
Scioderm Plans To License Pharmaceuticals To Develop Topical Products 17
GlaxoSmithKline Extends Licensing Agreement With Amicus Therapeutics For Amigal 17
Amicus Therapeutics Raises USD258.8 Million in Public Offering of Shares 19
Amicus Therapeutics Raises USD103.5 Million in Public Offering of Shares 20
Amicus Therapeutics Announces Public Offering Of Shares For Up To US$40 Million 22
Amicus Therapeutics Completes Private Placement Of Securities For US$15 Million 22
Amicus Therapeutics Files Registration Statement For Public Offering Of Securities For US$145 Million 24
Amicus Therapeutics Completes Public Offering Of Common Stock For US$65 Million 24
Amicus Therapeutics Raises USD250 Million in Private Placement of 3% Notes Due 2023 26
Amicus Therapeutics Announces Public Offering Of Debt Securities For US$25 Million 27
Amicus Therapeutics Acquires MiaMed 28
Amicus Therapeutics Acquires Scioderm 29
Amicus Therapeutics Acquires Callidus Biopharma, Drug Discovery Company, For US$130 Million 30
Amicus Therapeutics Inc, Key Competitors 32
Amicus Therapeutics Inc, Key Employees 33
Amicus Therapeutics Inc, Subsidiaries 34

List of Figures
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Amicus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Amicus Therapeutics Inc (FOLD):企業のM&A・提携動向(医療分野)(Amicus Therapeutics Inc (FOLD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆